Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),SCLC (Small Cell Lung Cancer) Sotorasib in KRAS G12C-Mutated aNSCLC: OS Data From the Global EAP Study-436 Aug 11, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Efti Plus Pembrolizumab Is Effective in 2nd-Line PD-1/PD-L1-Resistant Metastatic NSCLC Pts Aug 11, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),SCLC (Small Cell Lung Cancer) Patterns of response in mNSCLC after 2 and 4 CT cycles Aug 11, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),Other Cancers CEMI Monotherapy as 1L Treatment of Pts With Brain Metastases From aNSCLC Aug 07, 2023
Lung Cancer,Other Cancers Safety and Efficacy of Tusamitamab Ravtansine Combo in CEACAM5+ NSCLC Aug 07, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) 1L Cemiplimab for laNSCLC: Updated Subgroup Analyses Aug 03, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Updated Efficacy and Safety of Taletrectinib in Pts With ROS1+ NSCLC Jul 31, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Updated Data on DFS, OS, and Safety in Pts Receiving Adj Atezo After Neoadj Atezo Jul 31, 2023
